Filing Flows › Lemaitre Vascular (LMAT) › Q2 2026 › vs Q1 2026
Lemaitre Vascular (LMAT) Q2 2026 vs Q1 2026 (quarter over quarter)
Lemaitre Vascular's revenue rose $3.8M (+6%) from $66.6M in Q1 2026 to $70.4M in Q2 2026. Gross margin 72.1% against 72.7% (-0.6 pts).
Lemaitre Vascular, Q2 2026: revenue $70.4M (+10% year over year), operating margin 29.0%, net earnings $17.1M, operating cash flow $16.0M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 72.1% | 72.7% | -0.6 pts |
| Operating margin | 29.0% | 26.7% | +2.3 pts |
| Net margin | 24.2% | 23.6% | +0.7 pts |
| Free cash flow margin | 19.4% | 18.5% | +0.9 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $70.4M | $66.6M | $3.8M | +6% |
| Gross profit | $50.8M | $48.4M | $2.4M | +5% |
| Cost of revenue | $19.6M | $18.2M | $1.5M | +8% |
| Other income, net | $1.8M | $1.9M | −$107K | -6% |
| Operating profit | $20.4M | $17.8M | $2.6M | +15% |
| Operating expenses | $30.4M | $30.6M | −$256K | -0.8% |
| Pre-tax earnings | $22.2M | $19.7M | $2.5M | +13% |
| Research & development | $4.8M | $4.1M | $787K | +19% |
| Sales & marketing | $14.4M | $14.5M | −$107K | -0.7% |
| General & admin | $11.1M | $12.0M | −$936K | -8% |
| Net earnings | $17.1M | $15.7M | $1.4M | +9% |
| Income tax | $5.1M | $4.0M | $1.1M | +29% |
| Depreciation & amortization | $2.7M | $2.6M | $39K | +1% |
| Share-based compensation | $1.9M | $2.1M | −$157K | -8% |
| Working capital & other | $5.7M | $5.3M | $381K | +7% |
| Operating cash flow | $16.0M | $15.1M | $872K | +6% |
| Free cash flow (OCF − capex) | $13.7M | $12.3M | $1.3M | +11% |
| Capital expenditures | $2.3M | $2.8M | −$470K | -17% |
Questions
How much did Lemaitre Vascular's revenue grow quarter over quarter in Q2 2026?
Lemaitre Vascular's revenue rose $3.8M (+6%) from $66.6M in Q1 2026 to $70.4M in Q2 2026. Gross margin 72.1% against 72.7% (-0.6 pts).